A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic mut1
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA me1
The company has secured 1.2 million euros from the Ministry of Science, Innovation and Universities’ call for public-private collaboration projects t1
Ferran Nadeu, a researcher in the IDIBAPS research group Molecular pathology of lymphoid neoplasms, has been awarded a Starting grant from the Europe1
Twenty-five years ago, Catalonia pioneered the launch of the first colorectal cancer screening programme in Spain. The first studies had appeared sho1
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapies1
Researchers from the Clinic-IDIBAPS lead an international study, published in The Lancet Respiratory Medicine, which demonstrates the importance of r1
An international study led by the Imaging of mood- and anxiety-related disorders research group at IDIBAPS has created a new brain atlas that identi1